Are you using the wrong jogging stroller? Here’s how to find the perfect one for your runs.

From budget buggies to speedy chariots, these strollers let you run with your child safely and comfortably.

RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) plus immunotherapy shows strong clinical benefit with 56 percent overall response rate in first-line recurrent or ...

Johnson & Johnson (NYSE:JNJ) today announced new results from the Phase 1b/2 OrigAMI-4 study showing that first-line treatment with investigational subcutaneous amivantamab and hyaluronidase-lpuj in ...

11 things to do in Lake and Sumter this weekend

From Blues-BQ to GeorgeFest to Scottish Highland fun, discover a packed schedule of festivals, concerts and family events this weekend plus a look ahead.
PharmiWeb

RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Breakthrough Therapy Designation for patients with advanced head and neck cancer

Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for subcutaneous amivantamab and hyaluronidase-lpuj as ...